Laboratory control of SK therapy.
D000208:Acute Disease; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D002908:Chronic Disease; D005340:Fibrinogen / Q000032:analysis / Q000378:metabolism; D005342:Fibrinolysis; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010447:Peptide Hydrolases; D010958:Plasminogen / Q000032:analysis; D012008:Recurrence; D012712:Serum Globulins; D012910:Snake Venoms; D012995:Solubility; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013916:Thrombelastography; D013917:Thrombin; D013997:Time Factors
D012712:Serum Globulins; D012910:Snake Venoms; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D010447:Peptide Hydrolases; D013300:Streptokinase; D013917:Thrombin